|
Market Cap (16-May) $64,879,684 (564th) |
Close (30-Jun) $0.180 |
Volume (30-Jun) 3,225,766 |
Shortsold (5-May) 10,361,283 (0.51%) (303rd) |
|
52w High $0.090 |
52w Low $0.031 |
P/E - |
EPS -0.01 |
IPD released this announcement to the ASX on 28 March 2023, 12:49. The announcement is not marked as price sensitive, and is 2 page(s) in length and 256.6kb in size.
You can view all announcements from IPD and see how they appear on a price chart on the announcements page.
At the date of this announcement, IPD was 0.175% short sold according to ASIC data. It was ranked the 422nd most shorted stock on the ASX. It is now ranked as the 303rd most shorted stock on the ASX with 0.511% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from IPD | |
|---|---|
| Revised Security Trading Policy | 30 June 2023, 8:18 |
| ImpediMed Achieves Critical Mass in First Key Target State | 29 June 2023, 9:32 |
| ImpediMed Updates Board for Growth in Oncology | 28 June 2023, 8:22 |
| ImpediMed NCCN Investor Update Conference Call Notification | 28 March 2023, 12:49 |
| NCCN Guidelines Now Recommend Bioimpedance Spectroscopy | 27 March 2023, 9:50 |
| Notification regarding unquoted securities - IPD | 17 March 2023, 17:22 |
| Change of Director's Interest Notice - Mr Donald Williams | 17 March 2023, 12:55 |
You must be logged in to post a reply.
ImpediMed 